Stark JL - Search Results

1

Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials.

Blauvelt A, Armstrong A, Merola JF, Strober B, de Cuyper D, Peterson L, Davies O, Stark JL, Lebwohl M. Blauvelt A, et al. Among authors: stark jl. J Am Acad Dermatol. 2024 Mar 4:S0190-9622(24)00438-9. doi: 10.1016/j.jaad.2024.02.039. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38447700 Free article.

2

PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol.

Walsh JA, Arledge T, Nurminen T, Peterson L, Stark J. Walsh JA, et al. J Rheumatol. 2018 Jul;45(7):922-928. doi: 10.3899/jrheum.170244. Epub 2018 May 1. J Rheumatol. 2018. PMID: 29717036 Free article. Clinical Trial.

3

Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry.

McLean RR, Sima AP, Beaty S, Low R, Spitzer RL, Stark JL, Lesser E, Lee E, Armstrong A. McLean RR, et al. Among authors: stark jl. Dermatol Ther (Heidelb). 2023 Nov;13(11):2739-2751. doi: 10.1007/s13555-023-01027-6. Epub 2023 Sep 27. Dermatol Ther (Heidelb). 2023. PMID: 37755689 Free PMC article.

4

Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry.

McLean RR, Sima AP, Beaty S, Jones EA, Eckmann T, Low R, McClung L, Spitzer RL, Stark J, Armstrong A. McLean RR, et al. Dermatol Ther (Heidelb). 2023 Nov;13(11):2753-2768. doi: 10.1007/s13555-023-01028-5. Epub 2023 Sep 27. Dermatol Ther (Heidelb). 2023. PMID: 37759099 Free PMC article.

5

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases.

Curtis JR, Winthrop K, Bohn RL, Suruki R, Siegel S, Stark JL, Xie F, Yun H, Chen L, Deodhar A. Curtis JR, et al. Among authors: stark jl. ACR Open Rheumatol. 2021 Nov;3(11):743-752. doi: 10.1002/acr2.11316. Epub 2021 Sep 22. ACR Open Rheumatol. 2021. PMID: 34550648 Free PMC article.

6

One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry.

Harrold LR, Litman HJ, Saunders KC, Dandreo KJ, Gershenson B, Greenberg JD, Low R, Stark J, Suruki R, Jaganathan S, Kremer JM, Yassine M. Harrold LR, et al. Arthritis Res Ther. 2018 Jan 2;20(1):2. doi: 10.1186/s13075-017-1496-5. Arthritis Res Ther. 2018. PMID: 29329557 Free PMC article.

7

Barriers to treatment optimization and achievement of patients' goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry.

Gavigan K, Nowell WB, Serna MS, Stark JL, Yassine M, Curtis JR. Gavigan K, et al. Among authors: stark jl. Arthritis Res Ther. 2020 Jan 7;22(1):4. doi: 10.1186/s13075-019-2076-7. Arthritis Res Ther. 2020. PMID: 31910893 Free PMC article.

8

Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.

Magrey M, Schwartzman S, de Peyrecave N, Sloan VS, Stark JL. Magrey M, et al. Among authors: stark jl. Medicine (Baltimore). 2022 Apr 15;101(15):e29063. doi: 10.1097/MD.0000000000029063. Medicine (Baltimore). 2022. PMID: 35475794 Free PMC article. Review.

9

Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.

Sheahan A, Anjohrin S, Suruki R, Stark JL, Sloan VS. Sheahan A, et al. Among authors: stark jl. Clin Rheumatol. 2024 Jun;43(6):1897-1907. doi: 10.1007/s10067-024-06945-0. Epub 2024 Apr 25. Clin Rheumatol. 2024. PMID: 38658403 Free PMC article.

10

Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy.

Anjohrin S, Sheahan A, Suruki R, Stark JL, Sloan VS. Anjohrin S, et al. Among authors: stark jl. Rheumatol Ther. 2021 Dec;8(4):1651-1659. doi: 10.1007/s40744-021-00359-z. Epub 2021 Sep 7. Rheumatol Ther. 2021. PMID: 34491550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page